These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9463099)

  • 1. Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.
    Kinsella TJ; Glaubiger D; Diesseroth A; Makuch R; Waller B; Pizzo P; Glatstein E
    Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1955-60. PubMed ID: 9463099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
    Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance.
    Miser JS; Kinsella TJ; Triche TJ; Tsokos M; Forquer R; Wesley R; Horvath K; Belasco J; Longo DL; Steis R
    J Clin Oncol; 1988 Mar; 6(3):484-90. PubMed ID: 3280743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
    Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of sarcomas of the chest wall using intensive combined modality therapy.
    Young MM; Kinsella TJ; Miser JS; Triche TJ; Glaubiger DL; Steinberg SM; Glatstein E
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):49-57. PubMed ID: 2643597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
    Meyers PA; Krailo MD; Ladanyi M; Chan KW; Sailer SL; Dickman PS; Baker DL; Davis JH; Gerbing RB; Grovas A; Herzog CE; Lindsley KL; Liu-Mares W; Nachman JB; Sieger L; Wadman J; Gorlick RG
    J Clin Oncol; 2001 Jun; 19(11):2812-20. PubMed ID: 11387352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pelvic sarcomas in adolescents and young adults with intensive combined modality therapy.
    Stea B; Kinsella TJ; Triche TJ; Horvath K; Glatstein E; Miser JS
    Int J Radiat Oncol Biol Phys; 1987 Dec; 13(12):1797-805. PubMed ID: 3679916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
    Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
    Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.
    Horowitz ME; Kinsella TJ; Wexler LH; Belasco J; Triche T; Tsokos M; Steinberg SM; McClure L; Longo DL; Steis RG
    J Clin Oncol; 1993 Oct; 11(10):1911-8. PubMed ID: 8410118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
    Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
    J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late follow-up of a short-term intensive regimen for Ewing's sarcoma.
    Marcus RB; Springfield DS; Graham-Pole JR; Heare TC; Enneking WF; Million RR
    Am J Clin Oncol; 1991 Oct; 14(5):446-50. PubMed ID: 1951181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?
    Laws HJ; van Kaick B; Pape H; Paulussen M; Göbel U
    Onkologie; 2003 Dec; 26(6):573-7. PubMed ID: 14709933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG).
    Shankar AG; Pinkerton CR; Atra A; Ashley S; Lewis I; Spooner D; Cannon S; Grimer R; Cotterill SJ; Craft AW
    Eur J Cancer; 1999 Nov; 35(12):1698-704. PubMed ID: 10674016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.
    Evans RG; Nesbit ME; Gehan EA; Garnsey LA; Burgert O; Vietti TJ; Cangir A; Tefft M; Thomas P; Askin FB
    J Clin Oncol; 1991 Jul; 9(7):1173-80. PubMed ID: 2045857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
    Burdach S; Jürgens H; Peters C; Nürnberger W; Mauz-Körholz C; Körholz D; Paulussen M; Pape H; Dilloo D; Koscielniak E
    J Clin Oncol; 1993 Aug; 11(8):1482-8. PubMed ID: 8101562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of multimodal therapy in Ewing's sarcoma: a retrospective analysis of 20 patients.
    Ben-Arush M; Kuten A; Perez-Nahum M; Cohen Y; Bialik V
    J Surg Oncol; 1991 Sep; 48(1):51-5. PubMed ID: 1890840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81.
    Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J
    Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.